Is this you? Create Your Porfile
Avatar

Kaoru Masumoto

Dainippon Sumitomo Pharma Co., Ltd.

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Kaoru Masumoto is active.

Explore More

Publication

Featured researches published by Kaoru Masumoto.

Archive | 1998

2-aryl-8-oxodihydropurine derivative, process for the producing the same, medicinal compositions containing the same, and intermediates thereof

Teruya Murata; Kaoru Masumoto; Katsunori Kondo; Kiyoshi Furukawa; Makoto Oka

Archive | 2000

Medium comprising 2-aryl-8-oxodihydropurine derivative

Kiyoshi Furukawa; Masaki Kondo; Kaoru Masumoto; Koya Murata; Makoto Oka; 清 古川; 薫 増本; 晃哉 村田; 勝紀 近藤

Archive | 2000

2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives

Teruya Murata; Katsunori Kondo; Kaoru Masumoto; Hitoshi Kohayakawa; Kiyoshi Furukawa

Archive | 1998

5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives

Kazunori Ohno; Osamu Odai; Kaoru Masumoto; Kiyoshi Furukawa; Makoto Oka

Archive | 2004

5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1H)-ketone derivatives

Kazunori Ohno; Osamu Odai; Kaoru Masumoto

Archive | 2001

2-aryl-8-oxodihydropurine derivatives, process for producting same, medicinal conty. same, and intermediates thereof

Teruya Murata; Kaoru Masumoto; Katsunori Kondo

Archive | 2006

2-(Cyclic Aminocarbonyl) Indoline Derivative and Medicinal Composition Containing the Same

Katsunori Kondo; Kaoru Masumoto; Hitoshi Kohayakawa

Archive | 2000

２−アリール−８−オキソジヒドロプリン誘導体からなる医薬

Kiyoshi Furukawa; Masaki Kondo; Kaoru Masumoto; Koya Murata; Makoto Oka; 清 古川; 薫 増本; 晃哉 村田; 勝紀 近藤

Archive | 2000

Intermediates for 5-substituted-3-oxadiazolyl-1,6-Naphthyridin-2(1H)-one derivatives

Kazunori Ohno; Osamu Odai; Kaoru Masumoto; Kiyoshi Furukawa; Makoto Oka

Archive | 2000

Derives de 2-arylpurine-9-acetamide, leur procede de preparation, compositions medicinales les contenant et intermediaires des derives

Teruya Murata; Katsunori Kondo; Kaoru Masumoto; Hitoshi Kohayakawa; Kiyoshi Furukawa

Explore More

Collaboration

Dive into the Kaoru Masumoto's collaboration.

Top Co-Authors
Avatar

Kiyoshi Furukawa

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors
Avatar

Makoto Oka

Osaka University

View shared research outputs
Top Co-Authors
Avatar

Katsunori Kondo

Dainippon Sumitomo Pharma Co.

View shared research outputs
Top Co-Authors
Avatar

Hitoshi Kohayakawa

Dainippon Sumitomo Pharma Co.

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge